How many milliliters of reconstituted liposomal amphotericin B should be added to each 500 mL 5% dextrose (D5W) bag, and what infusion rate in mL per hour should be used for each dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Reconstitution and Administration of Amphotericin B Deoxycholate

For a 50 mg vial reconstituted and diluted in 500 mL of 5% dextrose (D5W), add the entire reconstituted vial to each bag; infuse at 62.5-83 mL/hr over 6-8 hours.

Step-by-Step Preparation

Reconstitution

  • Add 10 mL of sterile water (without bacteriostatic agent) directly to the 50 mg vial 1
  • Shake immediately until completely clear to create a 5 mg/mL concentrate 1
  • Critical: Use a needle ≥20 gauge 1

Dilution

  • Add the entire 10 mL of reconstituted solution (50 mg) to a 500 mL D5W bag 1
  • This creates a final concentration of 0.1 mg/mL (50 mg in 500 mL) 1
  • Verify D5W pH >4.2 before use - if pH <4.2, add buffer solution first 1

Infusion Rate Calculation

For 50 mg dose in 500 mL over 6-8 hours:

  • 6-hour infusion: 83 mL/hr
  • 8-hour infusion: 62.5 mL/hr

The infusion rate should not exceed 0.08 mg/kg/hour 2. For a typical adult (60-70 kg), this translates to approximately 5-6 mg/hour maximum, which aligns with the 6-8 hour infusion window for 50 mg 2.

Critical Safety Considerations

Pre-medication Required

  • Administer diphenhydramine or acetaminophen 30-60 minutes before infusion to prevent infusion-related reactions 2

Nephrotoxicity Prevention

  • Give 1 liter of normal saline before AND after the amphotericin infusion 2
  • This is strongly recommended to minimize kidney damage

Dosing Pitfalls

Do NOT prepare 25 mg (one vial) in 500 mL - this creates excessive insoluble particles that will clog filters and prevent complete drug delivery 3. Research shows only 11.3% of drug flows through when 25 mg is diluted in 500 mL 3.

Acceptable preparations:

  • 50 mg in 500 mL (recommended) 3
  • 25 mg in 250 mL 3
  • 25 mg in 50 mL 3

Storage and Handling

  • Store prepared solutions at 4-8°C (refrigerated) 4
  • Use within 24 hours of preparation 4
  • Never use saline or solutions containing bacteriostatic agents - these cause precipitation 1
  • Protection from light is unnecessary 4

Filter Requirements

If using an inline filter, ensure pore diameter ≥1.0 micron to allow passage of the colloidal dispersion 1

Monitoring During Infusion

Record vital signs (temperature, pulse, respiration, blood pressure) every 30 minutes for the first 2-4 hours 1

Related Questions

How should 300 mg of liposomal amphotericin B be diluted?
For a 365 mg dose of liposomal amphotericin B, should I reconstitute seven 50 mg vials with 10 mL sterile water each, withdraw 70 mL from a 500 mL 5 % dextrose (D5W) bag, add the reconstituted drug, and infuse the mixture over six hours once daily for seven days?
Should I prepare a 365 mg dose of liposomal amphotericin B (amphotericin B liposomal) by mixing seven reconstituted vials into a 500 mL bag of 5% dextrose (5D) and infuse it over six hours?
Should the 365 mg dose of liposomal amphotericin B for a 73‑kg adult be administered over six hours?
What volume of 5% dextrose (D5W) is required to dilute 160 mg of amphotericin B (deoxycholate)?
What is the appropriate management of an intravenous catheter after tourniquet release, including monitoring and care instructions?
Please provide a complete SOAP note for a patient presenting with acute uncomplicated appendicitis, including history, physical examination findings, laboratory and imaging results, assessment, and a detailed management plan.
Can prolonged tourniquet use during IV catheter placement lead to crush‑syndrome–like complications?
Can a brief rubber tourniquet applied for peripheral IV access cause crush‑syndrome–type complications or other adverse effects?
In an adult with eczema or lichen simplex chronicus, how should topical doxepin be used to minimize skin sensitivity and photosensitivity?
What management steps are indicated after a rubber IV tourniquet has been applied for more than three hours, despite return of pulses and color?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.